The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.00
Bid: 295.00
Ask: 299.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.356%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 296.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Europe ends higher but New York struggles

Mon, 14th Nov 2022 16:55

(Alliance News) - European equities surrendered some afternoon gains but made a bright start to the week on Monday, shaking off hawkish noise from the US Federal Reserve, while investors waited with bated breath for the outcome of talks between the leaders of the world's two leading economies.

Presidents Joe Biden and Xi Jinping tried to take some heat out of their simmering superpower rivalry Monday, during a three-hour summit that found common ground on Ukraine but left little doubt that stark differences remain.

Biden emerged from the meeting proclaiming that there need not be a new Cold War, as both leaders spoke of the desire to prevent high tensions from spilling over into conflict.

Xi told Biden that the two countries "share more, not less, common interests", according to a Chinese account of the meeting, sounding more conciliatory than the last three pandemic-filled years without face-to-face presidential meetings would suggest.

The FTSE 100 index closed up 67.13 points, 0.9, at 7,385.17. The blue-chip index had been 1.3% higher earlier in the afternoon, but sentiment weakened slightly after a less-than-stellar start to the week for stocks in New York.

The FTSE 250 edged up just 6.04 points to 19,622.25. The AIM All-Share closed down 3.29 points, 0.4%, at 851.55.

The Cboe UK 100 ended up 0.9% at 739.02, the Cboe UK 250 closed down 0.1% at 16,921.03, and the Cboe Small Companies ended up 0.4% at 12,806.22.

In European equities on Monday, the CAC 40 in Paris ended up 0.2%, while the DAX 40 in Frankfurt ended up 0.6%.

"Fed speakers might have been out this weekend stressing the need to keep raising rates, but last week's CPI figure continues to provide the foundation for reviving bullish sentiment. European markets have put their best foot forward today," IG analyst Chris Beauchamp commented.

The dollar was largely supported on Monday, amid hawkish noise from the Federal Reserve.

Christopher Waller, a member of Federal Reserve Board of Governors, warned at a conference in Sydney that the endpoint to interest rate increases was likely "ways to go", downplaying cooler US consumer inflation data last week.

Reuters reported Waller said that while interest rates will rise in less sizeable increments, the Fed is not "softening" its inflation fight.

Markets should look at the "endpoint" of increases, not the pace of rate hikes.

The pound was quoted at USD1.1714 late Monday afternoon in London, down from USD1.1781 late Friday. The euro traded at USD1.0334, up from USD1.0326 on Friday. Against the yen, the dollar was quoted at JPY140.45, up from JPY139.07 on Friday.

The pound will be in focus this week due to the upcoming autumn budget.

UK Prime Minister Rishi Sunak has insisted that the budget's difficult decisions will have "fairness and compassion at their heart" after the chancellor warned everyone will be paying more tax.

The PM and Jeremy Hunt are considering allowing local authorities to impose larger rises in council tax next year to raise money for social care, among their tax-hiking measures.

IG's Beauchamp added: "Sterling-watchers have their work cut out for them this week. Normally unemployment data, inflation figures and retail sales would be enough to keep track of, but the fiscal statement this week adds spice to the pound's outlook. Barring some remarkable surprises, this week is not likely to be overflowing with good news for the UK economy."

Hunt is expected to make the support plan for energy bills less generous from April, instead switching to more targeted measures in order to save the Treasury billions, PA reported.

He is considering increasing the windfall tax on oil and gas giants from 25% to 35% while also expanding the levy to electricity generators.

Harbour Energy slid 9.4% in London on Monday, amid the windfall tax fears.

On the up, however, Informa surged 5.9%.

The London-based business publisher and events organiser upgraded its full-year outlook on the back of strong underlying revenue growth in the first 10 months of the year.

In the 10-months to October, it reported underlying revenue growth of 41% in its continuing business against the previous year. For 2021, Informa had posted an underlying revenue of GBP1.80 billion.

"Growth has been consistent across all specialist markets and all geographic regions where Covid restrictions have been removed and are fully open. In the US, customer demand has been particularly strong as business to business activity has returned at pace," Informa said.

Elsewhere in London, ME Group added 10% after it upgraded its full-year outlook thanks to a first-half performance which came in ahead of expectations.

The instant-service equipment firm noted a strong recovery across continental Europe and robust consumer demand for all its services, leading it to up its guidance for the year.

Revenue is now expected to be between GBP256 million and GBP262 million for the full-year ended October 31, up from GBP257 million previously. Earnings before interest, taxation, depreciation, and amortisation is now expected between GBP82 million and GBP85 million, up from between GBP79 million and GBP84 million previously.

On AIM, biopharmaceutical firm Hutchmed jumped 16% on positive trial results.

It said its gastric cancer treatment fruquintinib, when combined with chemotherapy paclitaxel, met one of its primary endpoints of statistically significant improvement in progression-free survival during a phase-three study in 703 patients.

Progression-free survival is the length of time following treatment that a patient lives with the disease but does not see their condition worsen.

Stocks in New York were weaker at the time of the London equities close. The Dow Jones Industrial Average was down 0.1%, the S&P 500 was 0.3% lower and the Nasdaq Composite fell 0.9%.

Gold was priced at USD1,758.52 an ounce late Monday, down from USD1,763.60 late Friday. Brent oil fetched USD94.44 a barrel, down from USD96.32.

Tuesday's economic calendar has monetary policy minutes from the Reserve Bank of Australia posted overnight. There is also retail sales data from China before European markets open. There is unemployment data from the UK at 0700 GMT and the eurozone at 1000 GMT, before a US PPI reading at 1330 GMT.

The local corporate calendar has trading statements from defence firm BAE Systems and industrial turnaround specialist Melrose. Telecommunications company Vodafone posts half-year results, while Imperial Brands reports annual results.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Aug 2022 09:17

Hutchmed regulatory submission underway as fruquintinib trial succeeds

(Alliance News) - Hutchmed Ltd on Monday announced phase 3 of its fruquintinib FRESCO-2 study met its primary endpoint.

Read more
1 Aug 2022 15:16

TRADING UPDATES: Belvoir, Ingenta revenue up; Symphony revenue down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2022 15:59

UK earnings, trading statements calendar - next 7 days

Tuesday 26 July 
Aberforth Smaller Companies Trust PLCHalf Year Results
Ascential PLCHalf Year Results
Bytes Technology Group PLCTrading Statement
Capital & Counties Properties PLCHalf Year Results
Cohort PLCFull Year Results
Compass Group PLCTrading Statement
Dotdigital Group PLCTrading Statement
Drax Group PLCHalf Year Results
easyJet PLCTrading Statement
Ergomed PLCTrading Statement
Franchise Brands PLCHalf Year Results
Games Workshop Group PLCFull Year Results
Gore Street Energy Storage Fund PLCFull Year Results
Greencore Group PLCQ3 Results
John Menzies PLCTrading Statement
Medica Group PLCTrading Statement
Mitie Group PLCTrading Statement
NewRiver REIT PLCTrading Statement
Playtech PLCTrading Statement
Reach PLCHalf Year Results
Ricardo PLCTrading Statement
Sabre Insurance Group PLCHalf Year Results
SME Credit Realisation Fund LtdFull Year Results
Trifast PLCFull Year Results
Tyman PLCHalf Year Results
Unilever PLCHalf Year Results
Vivo Energy PLCHalf Year Results
Wickes Group PLCTrading Statement
Wednesday 27 July 
Aptitude Software Group PLCHalf Year Results
BlackRock Energy & Resources Income Trust PLCHalf Year Results
Breedon Group PLCHalf Year Results
British American Tobacco PLCHalf Year Results
FirstGroup PLCTrading Statement
Fresnillo PLCQ2 Production Results
GSK PLCHalf Year Results
Hargreaves Services PLCFull Year Results
Hiscox LtdTrading Statement
Ibstock PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Lancashire Holdings LtdHalf Year Results
Lloyds Banking Group PLCHalf Year Results
Marston's PLCTrading Statement
Motorpoint Group PLCTrading Statement
musicMagpie PLCHalf Year Results
Nichols PLCHalf Year Results
Primary Health Properties PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Reckitt Benckiser Group PLCHalf Year Results
Rio Tinto PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCHalf Year Results
Wizz Air Holdings PLCQ1 Results
Yourgene Health PLCFull Year Results
Thursday 28 July 
Airtel Africa PLCTrading Statement
Anglo American PLCHalf Year Results
Aveva Group PLCTrading Statement
BAE Systems PLCHalf Year Results
Barclays PLCHalf Year Results
Bodycote PLCHalf Year Results
BT Group PLCQ1 Results
Centrica PLCHalf Year Results
CVS Group PLCTrading Statement
De La Rue PLCTrading Statement
Diageo PLCFull Year Results
discoverIE Group PLCTrading Statement
Dr Martens PLCTrading Statement
Elementis PLCHalf Year Results
FDM Group PLCHalf Year Results
Forterra PLCHalf Year Results
Foxtons Group PLCHalf Year Results
GB Group PLCTrading Statement
Greencoat UK Wind PLCHalf Year Results
Hammerson PLCHalf Year Results
Headlam Group PLCTrading Statement
Inchcape PLCHalf Year Results
Indivior PLCHalf Year Results
Informa PLCHalf Year Results
ITV PLCHalf Year Results
Jupiter Fund Management PLCHalf Year Results
Logistics Development Group PLCTrading Statement
Metro Bank PLCHalf Year Results
Mitchells & Butlers PLCTrading Statement
Mortgage Advice Bureau (Holdings) PLCTrading Statement
Mothercare PLCFull Year Results
MySale Group PLC Trading Statement
National Express Group PLCHalf Year Results
Quixant PLCTrading Statement
Rathbones Group PLCHalf Year Results
Relx PLCHalf Year Results
Rentokil Initial PLCHalf Year Results
Restore PLCHalf Year Results
Robert Walters PLCHalf Year Results
Schroders PLCHalf Year Results
Segro PLCHalf Year Results
Shell PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
St James's Place PLCHalf Year Results
Vesuvius PLCHalf Year Results
Volex PLCHalf Year Results
Weir Group PLCHalf Year Results
Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Spectris PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
15 Jul 2022 13:20

IN BRIEF: Hutchmed starts phase I trial of HMPL-A83

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Begins phase I trial of HMPL-A83 for patients with advanced malignant neoplasms, in China. HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. Malignant neoplasms are cancerous tumours. It has "significant" potential to be used as a combination therapy with Hutchmed's existing portfolio, the firm says.

Read more
13 Jul 2022 09:35

IN BRIEF: Hutchmed presents solid results from lung cancer study

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Presents positive results from the Savannah phase two trial of Hutchmed and AstraZeneca PLC's savolitinib in combination with Astra's osimertinib in epidermal growth factor receptor-mutated non-small cell lung cancer patients.

Read more
6 Jul 2022 10:37

AIM WINNERS & LOSERS: Hutchmed down amid China Covid woes; Parkmead up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
6 Jul 2022 09:25

Hutchmed phase I trial for IMG-007 doses first patient

(Alliance News) - Hutchmed China Ltd on Wednesday announced the first patient has been dosed for its phase I trial for IMG-007.

Read more
1 Jun 2022 10:07

IN BRIEF: Hutchmed China wins cancer drug Tazverik approval in Hainan

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Receives approval for Tazverik from the Health Commission & Medical Products Administration of the Hainan province in China. The approval is for use in the Hainan pilot zone under the Clinically Urgently Needed Imported Drugs scheme, for the treatment of certain patients with epithelioid sarcoma and follicular lymphoma.

Read more
3 May 2022 12:14

LONDON MARKET MIDDAY: Stocks down as aggressive US Fed rate hike looms

(Alliance News) - Stock prices in London were lower at midday on Tuesday following the long bank holiday weekend in the UK, as markets globally prepare for a sharp US interest rate hike and similar moves by other central banks as they struggle to control inflation.

Read more
3 May 2022 11:29

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
3 May 2022 11:25

IN BRIEF: US FDA says Hutchmed's pancreatic drug needs more testing

Hutchmed (China) Ltd - Hong Kong-based biopharmaceuticals - The US Food & Drug Administration has rejected Hutchmed's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA says the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively. Chief Executive Officer & Chief Scientific Officer Weiguo Su comments: "Although this decision from the FDA is disappointing, we remain confident about the clinical value of surufatinib for NET patients and committed to making surufatinib available to patients globally. We look forward to working with the agency to evaluate its feedback."

Read more
3 May 2022 08:57

LONDON MARKET OPEN: BP rises despite taking hit from Rosneft exit

(Alliance News) - Stock prices in London opened lower on Tuesday following the long bank holiday weekend, with BP shares rising as the oil major planned to return cash to shareholders amid calls by some UK politicians for a windfall profit tax on energy companies.

Read more
3 May 2022 07:53

LONDON MARKET PRE-OPEN: BP swings to quarterly loss after Rosneft exit

(Alliance News) - Stock prices in London are seen opening lower on Tuesday, after the long bank holiday weekend in the UK, as concerns rise over aggressive monetary policy tightening by the US Federal Reserve.

Read more
25 Apr 2022 10:45

AIM WINNERS & LOSERS: musicMagpie sells on new platform; Hutchmed down

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Apr 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 21 April 
Alliance Trust PLCAGM
Ibstock PLCAGM
Journeo PLCAGM
Relx PLCAGM
STV Group PLCAGM
Ruffer Investment Co LtdEGM re share issue
Friday 22 April 
Bellevue Healthcare Trust PLCAGM
Faron Pharmaceuticals LtdAGM
Murray International Trust PLCAGM
Monday 25 April 
Belluscura PLCAGM
Capital Gearing Trust PLCGM re non pre-emptive share issue
Cloudbreak Discovery PLCGM re Crescita equity drawdown agreement
Hikma Pharmaceuticals PLCAGM
JPMorgan US Smaller Cos Investment Trust PLCAGM
Polymetal International PLCAGM
Symphony International Holdings LtdAGM
Tuesday 26 April 
Aquis Exchange PLCAGM
Elementis PLCAGM
GlobalData PLCAGM
Oriole Resources PLCAGM
RPS Group PLCAGM
SigmaRoc PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Wednesday 27 April 
Drax Group PLCAGM
EP Global Opportunities Trust PLCAGM
Global Invacom Group LtdAGM
Hutchmed (China) LtdAGM
London Stock Exchange Group PLCAGM
McKay Securities PLCGM re Workspace offer
Nichols PLCAGM
Persimmon PLCAGM
Primary Health Properties PLCAGM
VH Global Sustainable Energy Opportunities PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.